Staurosporine (stsp) is a kinase inhibitor which induces cornified envelope assembly and terminal differentiation in normal and neoplastic mouse keratinocytes. In the tumorigenic cell lines 308 and SP-1 experiments were performed to determine if this effect was due only to activation of transglutaminases (TGases) already residing within the cell, or whether stsp was capable of inducing a full program of differentiation. Assessment of keratinocyte differentiation-specific protein expression in neoplastic cells revealed that expression of the suprabasal marker SPR-1 and the granular markers loricrin and filaggrin were induced by stsp. Protein expression was controlled by changes in mRNA expression, determined by Northern blotting. Transcripts for the TGase isoforms TG K and TG E were also induced by stsp in SP-1 cells, whereas only TG K expression was increased in 308 cells, which appear not to express TG E . Protein kinase C (PKC) activation is required for differentiation in normal mouse keratinocytes. To determine if stsp induces differentiation in neoplastic cells by regulation of this signaling pathway cells were treated with the specific PKC inhibitor GF 109203X or with different concentrations of bryostatin 1 to down-regulate specific isoforms of PKC prior to and during treatment with stsp. Stsp-induced protein cross-linking and marker expression were inhibited by GF 109203X, suggesting paradoxical activation of PKC by stsp. PKC a, e and 5, but not PKC T) and C,, were down-regulated by treating both cell types with bryostatin; pre-treatment of cells with bryostatin inhibited stsp-induced protein cross-linking and marker expression, suggesting a necessity for the a, 8 and/or e isoforms in stsp-induced differentiation.
Introduction
Neoplastic keratinocytes exhibit an attenuated response to normal differentiation stimuli such as elevated Ca 2+ and phorbol esters (1, 2) . This appears to be the earliest phenotypic alteration recognized following the initiation event (3) . It has been proposed that this change provides a selective advantage for initiated cells during tumor promotion with phorbol esters, since these agents are potent inducers of *Abbreviations: PKC, protein kinase C; stsp, staurosporine; TGase, transglutaminase; DMBA, 7,12-dimethylbenz [a] anthracene; TPA, 12-0-tetradecanoylphorbol-13-acetate.
© Oxford University Press terminal differentiation in normal keratinocytes (4, 5) . At the biochemical level, some disturbance in protein kinase C (PKC*) signaling pathways occurs in initiated cells. Although there is little difference between the PKC isoforms expressed in neoplastic cells compared with normal mouse keratinocytes, each expressing PKC a, 8, 8 , r\ and t, (6) , there is a difference in PKC activity and isoform phosphorylation status. In 308 and SP-1 cells (initiated mouse keratinocyte cell lines; 1) and mouse keratinocytes transduced with v-ras
Ha by a defective retroviral vector, which are also initiated and produce benign tumors in vivo, PKC 8 is phosphorylated on tyrosine residues, which reduces the inherent activation potential of the enzyme (7). This is not the case in normal keratinocytes cultured under the same conditions (7) and this disparity may result in poor responses to differentiation stimuli during neoplastic transformation. In contrast, the activity of PKCa is increased in v-ras Ha keratinocytes (8) and this may be related to the high levels of diacylglycerol found in these cells (9) .
Unlike phorbol esters, the microbial alkaloid staurosporine (stsp) is able to induce the final stage of the keratinocyte differentiation program, cornified envelope assembly, in both normal and neoplastic cells (10,11). Cross-linked protein envelopes generated in keratinocytes in response to stsp could be the consequence of activation of transglutaminase (TGases) already residing within the cell, as previous studies have demonstrated increased activity of these endogenous protein cross-linking enzymes after treatment of keratinocytes with stsp (10,11). Alternatively, stsp may be capable of inducing a full program of differentiation, inducing the synthesis of differentiation-specific proteins involved in the terminal phase of keratinocyte differentiation, such as the granular cell markers loricrin, filaggrin, SPR-1 and also TGases, ultimately triggering the assembly of cornified envelopes as the terminal phase of the process (12). This distinction is important, because it may reveal the specific target of stsp action, as this is an agent that induces terminal differentiation and complete regression in squamous cell tumors in vivo (13) . Stsp is a non-specific kinase inhibitor which was originally utilized for its ability to inhibit PKC (14) , but is now known to inhibit a broad range of serine/theonine and tyrosine-specific kinases (15, 16) . In normal keratinocytes stsp-induced comification appears to be a consequence, at least in part, of a paradoxical activation of PKC (11) . In neoplastic SP-1, 308 and v-ra.y Ha -infected keratinocytes previous studies have shown that stsp inhibits the tyrosine phosphorylation of PKC 8 (7) and may thus induce differentiation by up-regulating the catalytic ability of this PKC isoform.
The objectives of this study were therefore to assess whether stsp was capable of inducing a sequential differentiation program in neoplastic keratinocytes or whether a simpler process was occurring. The role of the PKC signaling pathway and individual PKC isoforms in stsp-induced maturation of neoplastic keratinocytes was also assessed. (19) , which were subjected to electrophoresis. Western blotting and detection of differentiation marker proteins with antibodies and enhanced chemiluminescence as described in Materials and methods. Expression of KI4 was used to demonstrate protein loading, as the amount of this protein is unaffected by keratinocyte differentiation (19) . Results are representative of three separate experiments.
Materials and methods

Reagents
Stsp and GF 109203X were purchased from Calbiochcm (La Jolla, CA). Bryostatin 1 was obtained from the Pharmaceutical Resources Branch of the 1260 National Cancer Institute (Bethesda, MD). All reagents were dissolved in dimethyl sulfoxide and stored at -20°C. Cell culture 308 cells were established as cells resistant to calcium-induced growth arrest from BALB/c mouse skin initiated with 7,12-dimethylbenz[a]anthracene (DMBA) and SP-1 cells were isolated from papillomas produced in Sencar mice by DMBA initiation and 12-O-tetradecanoylphorbol-l3-acetate (TPA) promotion (1) . Both cell types were grown routinely in Eagle's minimal essential medium with 8% chelex-treated fetal calf serum and 0.2% penicillin/ streptomycin solution (Antibiotic Solution; Gibco). The [Ca 2+ ] in the medium was adjusted to 0.05 mM, the concentration at which cultured normal mouse keraunocytes maintain a basal cell-like population (17) . In some experiments [Ca 2+ ] was increased to 1.4 mM coincident with the addition of stsp.
Cormfied envelope assay
Cross-linked protein envelopes were quantified as described (18), with modifications. Cell monolayers were scraped into 2% SDS, 20 mM dithiothreitol in phosphate-buffered saline. Unattached cells were pelleted from the medium and were pooled with scraped cells. Samples were then boiled for 10 min to dissolve material other than cross-linked protein. Comified envelopes were isolated, fixed and stained with Coomassie blue G250 on RC60 membrane (Schleicher & Schuell) using a 96 well dot blot apparatus as described (18). Spots were excised and eluted with 1% NH 4 OH concentrated solution, 66% methanol overnight. Absorbance of eluate was measured on a Titertek plate reader at 600 nm.
Western blots
Whole cell lysates were prepared as described (19) . Proteins were resolved by PAGE followed by Western blotting (20) . PKC a, 5, e, r| and C, were detected using antibodies obtained from the sources indicated (20) Antibodies to filaggrin, loricrin and keratin 14 (K14) were generated within the laboratory (19, 21) . SPR-1 was detected using an antibody prepared in rabbits to the Cterminus of the mouse sequence (22) . Specific proteins were visualized by incubation of blots with appropriate horseradish peroxidase-linked secondary antibodies at 1:5000 dilution (BioRad), followed by detection of luminol chemiluminescence (Renaissance, DuPont NEN) using Kodak XAR film. Northern blots Cells were solubilized in 4 M guanidine isothiocyanate, 25 mM sodium citrate, 0.5% sodium lauroyl sarcosinate and 0.1 M 2-mercaptoethanol prior to total RNA purification using phenol/chloroform as described (Ambion) (23) RNA was resolved and blots were pre-hybridized as described (24) . TGK mRNA was detected by hybridization to rat cDNA fragments (25) in plasmid vectors kindly donated by Dr R.Rice (University of California, Davis, CA). TGE mRNA was detected using DNA complementary to bases 2158-2217 (3' non-coding region) of mouse TG E (26) or a 684 bp RT-PCR product generated with primers 5'-GGCTTTGGACAAACTAAAC-3' (upstream) and 5'-GATAGTAGGGAATTTATTGCA-3' (downstream) inserted into a plasmid vector (Invitrogen). Either probe gave identical results. SPR-1 was identified with a 420 bp PCR product from the coding portion of mouse SPR-1 (22) . The 18S rRNA probe was obtained from ATCC (Rockville, MD). Plasmidinserted fragments were used for loricrin (3' non-coding region) (21) and profilaggnn (19) . Probes were labeled with 32 P by end-labeling for the TGE 60mer or by nick translation.
Results
Staurosporine induces cross-linked protein in 308 and SP-1 cells
The kinase inhibitor stsp is capable of inducing comified envelope assembly in both normal and neoplastic keratinocytes (11) . In normal mouse keratinocytes stsp has a biphasic dose-response effect, being most effective at 10 nM, and cornification is augmented by raising extracellular calcium from 0.05 to 1.4 mM (27) . When 308 ( Figure 1A present within the cell. Therefore, in order to establish whether stsp was inducing a differentiation program in 308 and SP-1 cells culminating in cornification or whether a simpler process was occurring cells were incubated with stsp for 24 h, then tested by Western blot analysis for expression of keratinocyte differentiation-specific proteins associated with the terminal phase of the differentiation program ( Figure 2 ). In both cell lines the suprabasal differentiation marker SPR-1 was detected as a broad band and expression was augmented slightly by high calcium concentration alone. This protein was greatly induced by stsp (5-100 nM) in both cell types at both calcium concentrations. The granular cell markers loricrin and filaggrin were also induced by stsp in both cell types. There was little induction of filaggrin by stsp in medium with 0.05 mM Ca 2+ , but raising calcium to 1.4 mM in the absence of stsp increased expression of this marker, which was then further increased by stsp. In the case of filaggrin there appeared to be a stsp dose optimum of 5-50 nM. Loricrin expression was increased by raising extracellular calcium alone in 308 cells. In both cell types stsp augmented expression of loricrin in either 0.05 or 1.4 mM Ca 2+ medium, with a greater response detected in SP-1 cells (Figure 2 ).
Stsp induces mRNA for differentiation-specific marker proteins in 308 and SP-1 cells
To assess whether stsp-induced differentiation marker expression was downstream from changes in mRNA expression or whether stsp was eliciting post-transcriptional effects to alter protein expression mRNA was analyzed by Northern blotting (Figure 3 ). This experiment also provided an opportunity to study the effect of stsp on expression of TGase isoforms, as stsp increases TGase activity in 308 and SP-1 cells (11), but antibodies to mouse TG K and TG E were unavailable to study protein expression. Expression of mRNA encoding SPR-1 and profilaggrin closely reflected expression of the proteins in that stsp induced both and expression of profilaggrin was enhanced in 1.4 mM Ca 2+ . Transcripts for loricrin were difficult to detect and did not consistently increase in response to stsp. In SP-1 cells mRNA for TG K for the indicated time points or in 1.4 mM Ca 2+ alone for the same time periods. Cells were harvested and total mRNA was isolated. Samples were subjected to Northern blotting, and blots were visualized for differentiation-specific mRNA.
Fig . 5 . Down-regulation of PKC isoforms by bryostatin. Cells were incubated in medium containing 0.05 mM Ca 2+ with bryostatin 1 at the indicated concentrations for 16 h. Total cell lysates were then prepared, which were electrophoresed, blotted onto nitrocellulose and isoforms of PKC were visualized by immunoblotting as described in Materials and methods. Results were repeated in a separate experiment. differentiation-specific proteins (Figure 4 ) revealed that SPR-1 was maximally induced at or beyond 24 h incubation with stsp. Similarly, in medium with 0.05 mM Ca 2+ transcripts for TGases were induced by 8 h and sustained during the 24 h study period. In medium containing 1.4 mM Ca 2+ induction of TGase mRNA was optimal by 12 h, with attenuation of transcripts by 24 h. In SP-1 cells TGases E and K appear to be expressed coincidentally, similar to the response of normal keratinocytes to stsp (27) .
The response of 308 and SP-1 cells to stsp can be attenuated by inhibition or down-regulation of PKC
The ability of stsp to induce the differentiation of normal mouse keratinocytes has been attributed to a paradoxical activation of PKC (11) . To assess whether the effects of stsp observed in the neoplastic cell lines 308 and SP-1 could be attributed to the same mechanism cells were incubated with the specific PKC inhibitor GF 109203X prior to and during treatment with stsp. Alternatively, in order to determine the necessity of individual PKC isoforms for the effect of stsp on keratinocyte differentiation, cells were incubated with different concentrations of bryostatin 1 for 16 h to induce selective PKC isoform down-regulation prior to treatment with stsp (20, 24) (Figure 5 ). Although 308 and SP-1 cells proliferated normally and their morphology was little changed when incubated in the presence of 0.01-1000 nM bryostatin 1 in medium with 0.05 mM Ca 2+ for 16 h, certain PKC isoforms were down-regulated in essentially the same dosedependent fashion in both cell types ( Figure 5 ). There was no reproducible down-regulation of PKC r) or ^ at this time point with any concentration of bryostatin. At 0.1-1 nM, PKC 8 was substantially down-regulated, but at 10-1000 nM bryostatin only induced a partial down-regulation of this isoform. At concentrations exceeding 0.01 nM, PKC e underwent a partial down-regulation, which was of the same magnitude from 0.1 to 1000 nM. PKC a was partially lost after 16 h incubation in 1 nM bryostatin in SP-1 cells and completely down-regulated at 10-1000 nM in both cell lines.
The effect of prior down-regulation of PKC isoforms with bryostatin or inhibition of PKC with GF 109203X on stspinduced protein cross-linking was tested ( Figure 6 ). In 308 ( Figure 6A ) or SP-1 ( Figure 6B ) cells pre-incubation with 0.01 nM bryostatin had no effect on stsp-induced cross-linking, 0.1 nM partially abrogated cross-linking and 1-1000 nM bryostatin completely abolished it. Additionally, pre-incubation with GF 109203X blocked stsp-induced protein cross-linking.
Stsp-induced differentiation marker expression was also Cells were incubated with bryostatin 1 (I and 1000 nM) for 16 h, then the calcium concentration in the medium was raised from 0.05 to 1.4 mM and stsp was added. After a further 24 h cell samples were prepared. Total RNA was isolated and was subjected to Northern blot analysis. Blots were visualized for transcripts of differentiation-specific proteins. The experiment was repeated three times with similar results.
inhibited by pre-treatment with bryostatin or GF109203X ( Figure 7 ). Stsp-induced expression of SPR-1, loricrin and filaggrin was inhibited with increasing bryostatin concentration. Filaggrin expression was inhibited by pre-incubation with bryostatin concentration as low as 0.01 nM and was blocked at and above 0.1 nM. However, concentrations of bryostatin exceeding 0.01 nM were required to inhibit expression of loricrin and SPR-1, with loricrin being completely blocked by pre-incubation with 10 nM bryostatin and SPR-1 by 1000 nM.
To assess whether the inhibition of marker expression demonstrated on Western blots resulted from inhibition of mRNA expression or whether a post-translational mechanism was responsible, cells treated with bryostatin for 16 h prior to stsp were tested for differentiation marker mRNA by Northern blotting (Figure 8 ). As with filaggrin protein, stsp-induced profilaggrin mRNA expression was completely abolished when cells were co-incubated with 1 and 1000 nM bryostatin. SPR-1 transcripts were greatly reduced with 1 nM and were abolished at 1000 nM bryostatin, again following protein expression. This experiment also provided an opportunity to study the effect of selective PKC isoform down-regulation on expression of TGases. In 308 and SP-1 cells the effect of stsp on TGK mRNA expression was blocked by either concentration of bryostatin. However, in SP-1 cells expression of TG E was only partially inhibited by bryostatin, suggesting either a role for PKC r) or i^ in the regulation of TG E or effects on factors other than PKC.
Discussion
We have here demonstrated that stsp induces a sequential differentiation program in neoplastic keratinocytes involving the expression of differentiation-specific proteins, including the suprabasal marker SPR-1, loricrin and TGases, which catalyze the protein cross-linking reaction during cornified envelope assembly beneath the cell membrane (28) . Induction of differentiation by stsp in these neoplastic cells is dependent on an intact PKC signal transduction pathway. Ca 2+ appears to act in synergy with stsp for certain differentiation-specific phenomena in 308 and SP-1 cells. Expression of the marker filaggrin was only increased by stsp in culture conditions with high Ca 2+ , suggesting that gene expression may be modified by stsp and Ca 2+ via the same cellular signaling pathways or pathways subject to cross-talk. Stspinduced cross-linked protein production was increased in medium with raised Ca 2+ in SP-1 cells. Of interest, TG E was not induced or detected in 308 cells, indicating that this enzyme is not required for the cornification process to proceed to a terminal end point. The augmentation of stsp-induced protein cross-linking by Ca 2+ may be the result of Ca 2+ -induced activation of TGases, as these enzymes are Ca 2+ -dependent (28) . In normal human keratinocytes it has been postulated that stsp induces differentiation by raising intracellular Ca 2+ (29) , but this is an unlikely mechanism in the neoplastic keratinocytes tested, as 308 and SP-1 cells do not undergo differentiation in the presence of Ca 2+ up to 1.4 mM in the culture medium and 308 cells proliferate readily under these conditions (1) .
Stsp-induced differentiation requires the activation of PKC. Previous work had shown that in normal keratinocytes stsp mimics many of the effects of the potent PKC activator TPA. Ornithine decarboxylase activity is increased by both agents and can be inhibited by the PKC inhibitor H-7 or chronic TPA treatment to down-regulate PKC prior to agent application (30) . In normal human keratinocytes stsp-induced cornification can be inhibited by co-incubation with the specific PKC inhibitor Ro31-8220 (29) and in normal mouse keratinocytes stsp-induced cornification could be attenuated by pre-treatment with 60 nM bryostatin to down-regulate PKC (11) . Work presented here demonstrates that in the neoplastic cell lines tested stsp-induced cross-linked protein production and also differentiation marker protein expression are inhibited by coincubation with the specific PKC inhibitor GF 109203X, prior PKC down-regulation with bryostatin 1 (Figures 6 and 7) and also by down-regulating PKC with the phorbol ester 12-deoxyphorbol 13-phenylacetate (results not shown). Stsp induces cornification in 308 and SP-1 cells in a biphasic dosedependent manner, similar to the effect seen in normal mouse keratinocytes (10). The reduced activity of stsp at concentrations exceeding 50 nM may reflect cumulative toxicity, as it inhibits numerous kinases. Alternatively, the PKC inhibitory effect of stsp may become its predominant effect at high concentrations (31) . However, the current studies also reveal that specific markers of the differentiation program have somewhat different dose-response characteristics, indicating more than one target may exist for stsp in neoplastic cells.
Stsp inhibits the inherent tyrosine phosphorylation of PKC 8 coincidentally with the induction of differentiation in 308 and SP-1 cells, increasing the potential for activation of this isozyme in the process (7) . This modification to PKC 8 by stsp may be crucial to the unique properties of this compound, as potent PKC activators like TPA are ineffective at inducing differentiation in these cells (1) . In order to assess the involvement of individual PKC isozymes in the effects of stsp cells were treated with different concentrations of bryostatin 1 for 16 h to down-regulate PKC isoforms to different extents prior to application of stsp. Cross-linked protein synthesis was inhibited at concentrations of bryostatin at or exceeding 0.1 nM. PKC r\ and C, were not downregulated by bryostatin at any of the concentrations tested (0.01-1000 nM) and thus are not essential for the stsp-induced cornification response. At 0.1-1 nM bryostatin PKC 6 is almost completely down-regulated and the e isoform is partially downregulated; PKCa is completely lost at 10-1000 nM. This suggests modulation of multiple species of PKC, rather than a single isoform, for the differentiation response to stsp. The cornification response does not return at 10-1000 nM stsp, as would be expected if PKC 8 were the only isoform activated by stsp to induce cornification. However, it is possible that at high concentrations of bryostatin, although PKC 8 is not downregulated, its activity may be suppressed, as bryostatin can block the effects of the PKC activator TPA in certain circumstances (24, 32) , perhaps because of its longevity at the PKC receptor site (33) . Different PKC isoforms may also be involved in the expression of each stsp-induced differentiation marker, as different concentrations of bryostatin were required to inhibit stsp-induced expression of each protein (Figure 7 ). TGase expression was inhibited by pre-treatment with 1 and 1000 nM bryostatin and this effect probably has the greatest impact on inhibition of stsp-induced cornification by bryostatin. Stsp-induced SPR-1 expression was inhibited gradually by increasing concentrations of bryostatin, but only at 1000 nM was expression of this marker completely blocked, whereas filaggrin expression was inhibited at 0.01 nM bryostatin, a concentration at which PKC isoforms are not down-regulated by a 16 h treatment with bryostatin. The exquisite sensitivity of stsp-induced filaggrin expression for inhibition by bryostatin may be due to the additive effect of bryostatin and stsp on down-regulation of PKC isoforms, precluding marker expression, as stsp also down-regulates PKC at low nanomolar concentrations in an isoform-specific manner (34) . Thus further studies using genetic approaches will be required to state unequivocally the contribution of individual isozymes to the stsp response.
Evidence presented suggests that stsp activates PKC to induce differentiation in neoplastic keratinocytes, which is substantiated by the redistribution of PKC isoforms to new subcellular locations in 308 and SP-1 cells by stsp at low nanomolar concentrations (results not shown), this translocation usually indicating enzyme activation (35) . The mechanisms of this PKC activation remain unclear, although stsp has been demonstrated to actually increase the activity of kinases or increase protein phosphorylation in several systems (36, 37) . Stsp inhibits many kinases and the cumulative effects on many linked signaling pathways may lead to PKC activation at concentrations below those for inhibition of PKC isozymes by this agent. Stsp is a more specific inhibitor of the a isoform of PKC than PKC 8 and e (31) and this isozyme specificity may also have a bearing on its biological effects in neoplastic keratinocytes. Although stsp inhibits PKC, it has numerous positive effects on this signaling pathway in other cell types. In human neutrophils endogenous diacylglycerol levels are raised in response to stsp (38) and in platelets stsp enhanced the binding of phorbol 12,13-dibutyrate to its receptor, PKC, by increasing binding affinity and capacity in concert with increased membrane localization (39) . Therefore, in neoplastic keratinocytes perhaps the myriad inputs into signaling pathways by this agent ultimately lead to activation of the PKC signaling pathway.
These results show clearly that the kinase inhibitor stsp induces a differentiation program in neoplastic keratinocytes and that activation of PKC isozymes is required for this effect. The a, 8 and/or e isoforms are the most likely isoforms required for differentiation, but the mechanism by which stsp accomplishes activation of these isozymes in tumor cells remains elusive. To date few specific agents are available for the treatment of skin neoplasias. Topically applied stsp is capable of inhibiting tumor growth in a mouse skin tumor experimental model (13) . Evidence from this study suggests that stsp inhibits tumor growth through induction of differentiation and thus could be a prototype for specific differentiation therapy of neoplasias of the skin.
